<Version><xmlsource>This XML content was developed by AHRQ's contractor ECRI Institute for the National Quality Measures Clearinghouse (NQMC).</xmlsource><Section SecID="560" OrdBy="10" Name="General"><Field FieldID="11" OrdBy="20" ID="561" Name="Title" Type="text"><FieldValue Value="&lt;div class=&quot;content_title&quot;&gt;Perioperative care: percentage of patients undergoing procedures for which VTE prophylaxis is indicated in all patients who had an order for low-molecular weight heparin (LMWH), low-dose unfractionated heparin (LDUH), adjusted-dose warfarin, fondaparinux or mechanical prophylaxis to be given within 24 hours prior to incision time or 24 hours after surgery end time.&lt;/div&gt;" /></Field><Field FieldID="1" OrdBy="30" ID="562" Name="Source(s)" Type="citation"><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;American College of Surgeons, Physician Consortium for Performance Improvement®, National Committee for Quality Assurance. Perioperative care physician performance measurement set. Chicago (IL): American Medical Association, National Committee for Quality Assurance; 2006 Oct. 11 p.  [8 references]&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /></Field><Field Name ="UMLS Concepts"><FieldValue Value="ICD9CM: Other venous embolism and thrombosis of unspecified site  (453.9); Total knee replacement  (81.54)"/><FieldValue Value="MSH: Arthroplasty, Replacement, Hip ; Arthroplasty, Replacement, Knee ; Heparin, Low-Molecular-Weight ; Hip Fractures ; Orthopedic Procedures ; Perioperative Care ; Polysaccharides ; Thromboembolism ; Time Factors ; Venous Thrombosis ; Warfarin "/><FieldValue Value="MTH: Heparin, Low-Molecular-Weight ; Hip Fractures ; Hip Replacement Arthroplasty (procedure) ; Knee Replacement Arthroplasty (procedure) ; Polysaccharides ; Thromboembolism ; Venous Thrombosis ; Warfarin "/><FieldValue Value="PDQ: thromboembolism ; warfarin "/><FieldValue Value="SNOMEDCT_US: Anticoagulant prophylaxis ; Arthroplasty of knee ; Fondaparinux ; Insertion of hip prosthesis ; Low dose heparin prophylaxis ; Low molecular weight heparin ; Perioperative care ; Polysaccharide ; Thromboembolic disorder ; Venous thrombosis ; Warfarin "/></Field></Section><Section SecID="563" OrdBy="40" Name="Measure Domain"><Field FieldID="3025" OrdBy="50" ID="564" Name="Primary Measure Domain" Type="picklist-one"><FieldValue Value="Clinical Quality Measures: Process" /></Field><Field FieldID="3026" OrdBy="60" ID="565" Name="Secondary Measure Domain" Type="picklist-one"><FieldValue Value="Does not apply to this measure" /></Field></Section><Section SecID="566" OrdBy="70" Name="Brief Abstract"><Field FieldID="34" OrdBy="80" ID="567" Name="Description" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This measure is used to assess the percentage of patients undergoing procedures for which venous thromboembolism (VTE) prophylaxis is indicated in all patients who had an order for low-molecular weight heparin (LMWH), low-dose unfractionated heparin (LDUH), adjusted-dose warfarin, fondaparinux or mechanical prophylaxis within 24 hours prior to incision time or within 24 hours after surgery end time.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="21" OrdBy="90" ID="568" Name="Rationale" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This measure addresses venous thromboembolism (VTE) risk based on surgical procedure. VTE prophylaxis is appropriate for all patients undergoing these procedures regardless of individual &lt;i&gt;patient&lt;/i&gt; thromboembolic risk factors.*&lt;/p&gt;&#xD;&#xA;&lt;p class=&quot;Note&quot;&gt;*The following clinical recommendation statements are quoted &lt;span style=&quot;text-decoration: underline;&quot;&gt;verbatim&lt;/span&gt; from the referenced clinical guidelines and represent the evidence base for the measure:&lt;/p&gt;&#xD;&#xA;&lt;p class=&quot;Note&quot;&gt;Recommend that mechanical methods of prophylaxis be used primarily in patients who are at high risk of bleeding or as an adjunct to anticoagulant-based prophylaxis.&lt;/p&gt;&#xD;&#xA;&lt;p class=&quot;Note&quot;&gt;Recommend against the use of aspirin alone as prophylaxis against VTE for any patient group.&lt;/p&gt;&#xD;&#xA;&lt;p class=&quot;Note&quot;&gt;Recommend consideration of renal impairment when deciding on doses of low-molecular weight heparin (LMWH), fondaparinux, the direct thrombin inhibitors, and other antithrombotic drugs that are cleared by the kidneys, particularly in elderly patients and those who are at high risk for bleeding.&lt;/p&gt;&#xD;&#xA;&lt;p class=&quot;Note&quot;&gt;Moderate-risk general surgery patients are those patients undergoing a nonmajor procedure and are between the ages of 40 and 60 years or have additional risk factors, or those patients who are undergoing major operations and are less than 40 years of age with no additional risk factors. Recommend prophylaxis with low-dose unfractionated heparin (LDUH), 5,000 U bid or LMWH less than or equal to 3,400 U once daily.&lt;/p&gt;&#xD;&#xA;&lt;p class=&quot;Note&quot;&gt;Higher-risk general surgery patients are those undergoing nonmajor surgery and are greater than 60 years of age or have additional risk factors, or patients undergoing major surgery who are greater than 40 years of age or have additional risk factors. Recommend thromboprophylaxis with LDUH, 5,000 U tid or LMWH, greater than 3,400 U daily.&lt;/p&gt;&#xD;&#xA;&lt;p class=&quot;Note&quot;&gt;Recommend that thromboprophylaxis be used in all major gynecologic surgery patients.&lt;/p&gt;&#xD;&#xA;&lt;p class=&quot;Note&quot;&gt;For patients undergoing major, open urologic procedures, recommend routine prophylaxis with LDUH twice daily or three times daily.&lt;/p&gt;&#xD;&#xA;&lt;p class=&quot;Note&quot;&gt;Patients undergoing major orthopedic surgery, which includes hip and knee arthroplasty and hip fracture repair, represent a group that is at particularly high risk for VTE, and routine thromboprophylaxis has been the standard of care for greater than 15 years. Elective total hip replacement: routine use of LMWH, fondaparinux, or adjusted-dose VKA. Elective total knee arthroplasty: routine thromboprophylaxis using LMWH, fondaparinux, or adjusted-dose VKA. Hip fracture surgery: routine use of fondaparinux, LMWH, adjusted-dose VKA, or LDUH.&lt;/p&gt;&#xD;&#xA;&lt;p class=&quot;Note&quot;&gt;For major orthopedic surgical procedures, recommend that a decision about the timing of the initiation of pharmacologic prophylaxis be based on the efficacy-to-bleeding tradeoffs for that particular agent. For LMWH, there are only small differences between starting preoperatively or postoperatively, both options acceptable.&lt;/p&gt;&#xD;&#xA;&lt;p class=&quot;Note&quot;&gt;Recommend that thromboprophylaxis be routinely used in patients undergoing major neurosurgery. (American College of Chest Physicians [ACCP])&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="3500" OrdBy="100" ID="569" Name="Evidence for Rationale" Type="citation"><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;American College of Surgeons, Physician Consortium for Performance Improvement®, National Committee for Quality Assurance. Perioperative care physician performance measurement set. Chicago (IL): American Medical Association, National Committee for Quality Assurance; 2006 Oct. 11 p.  [8 references]&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Geerts WH, Pineo GF, Heit JA, Bergqvist D, Lassen MR, Colwell CW, Ray JG. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004 Sep;126(3 Suppl):338S-400S. [794 references] &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15383478&quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /></Field><Field FieldID="3022" OrdBy="110" ID="570" Name="Primary Health Components" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Perioperative care; timing of venous thromboembolism (VTE) prophylaxis;  low molecular weight heparin (LMWH); low-dose unfractionated heparin (LDUH); adjusted-dose warfarin; fondaparinux; mechanical prophylaxis&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="23" OrdBy="120" ID="571" Name="Denominator Description" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;All surgical patients aged 18 years and older undergoing procedures for which venous thromboembolism (VTE) prophylaxis is indicated in all patients (see the related &quot;Denominator Inclusions/Exclusions&quot; field)&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="24" OrdBy="130" ID="572" Name="Numerator Description" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Surgical patients who had an order for low molecular weight heparin (LMWH), low-dose unfractionated heparin (LDUH), adjusted-dose warfarin, fondaparinux or mechanical prophylaxis to be given within 24 hours prior to incision time or within 24 hours after surgery end time (see the related &quot;Numerator Inclusions/Exclusions&quot; field)&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="573" OrdBy="140" Name="Evidence Supporting the Measure"><Field FieldID="3027" OrdBy="150" ID="574" Name="Type of Evidence Supporting the Criterion of Quality for the Measure" Type="picklist-choice"><FieldValue Value="A clinical practice guideline or other peer-reviewed synthesis of the clinical research evidence" /></Field><Field FieldID="3501" OrdBy="160" ID="575" Name="Additional Information Supporting Need for the Measure" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Unspecified&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="3072" OrdBy="180" ID="577" Name="Extent of Measure Testing" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Unspecified&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="580" OrdBy="210" Name="State of Use of the Measure"><Field FieldID="3029" OrdBy="220" ID="581" Name="State of Use" Type="picklist-one"><FieldValue Value="Current routine use" /></Field><Field FieldID="3030" OrdBy="230" ID="582" Name="Current Use" Type="picklist-choice-3"><FieldValue Value="not defined yet" /></Field></Section><Section SecID="583" OrdBy="240" Name="Application of the Measure in its Current Use"><Field FieldID="3031" OrdBy="250" ID="584" Name="Measurement Setting" Type="picklist-choice"><FieldValue Value="Hospital Inpatient" /></Field><Field FieldID="3032" OrdBy="260" ID="585" Name="Professionals Involved in Delivery of Health Services" Type="picklist-choice-3"><FieldValue Value="not defined yet" /></Field><Field FieldID="3033" OrdBy="270" ID="586" Name="Least Aggregated Level of Services Delivery Addressed" Type="picklist-one"><FieldValue Value="Individual Clinicians or Public Health Professionals" /></Field><Field FieldID="3505" OrdBy="280" ID="587" Name="Statement of Acceptable Minimum Sample Size" Type="picklist-one"><FieldValue Value="Unspecified" /></Field><Field FieldID="41" OrdBy="290" ID="588" Name="Target Population Age" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Age greater than or equal to 18 years&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="42" OrdBy="300" ID="589" Name="Target Population Gender" Type="picklist-one"><FieldValue Value="Either male or female" /></Field></Section><Section SecID="660" OrdBy="310" Name="National Strategy for Quality Improvement in Health Care"><Field FieldID="3522" OrdBy="320" ID="661" Name="National Quality Strategy Aim" Type="text"><FieldValue Value="&lt;ul&gt;&lt;li&gt;Better Care&lt;/li&gt;&lt;/ul&gt;" /></Field><Field FieldID="3525" OrdBy="330" ID="662" Name="National Quality Strategy Priority" Type="text"><FieldValue Value="&lt;ul&gt;&lt;li&gt;Prevention and Treatment of Leading Causes of Mortality&lt;/li&gt;&lt;/ul&gt;" /></Field></Section><Section SecID="590" OrdBy="340" Name="Institute of Medicine (IOM) National Health Care Quality Report Categories"><Field FieldID="3163" OrdBy="350" ID="591" Name="IOM Care Need" Type="picklist-choice"><FieldValue Value="Getting Better" /></Field><Field FieldID="3164" OrdBy="360" ID="592" Name="IOM Domain" Type="picklist-choice"><FieldValue Value="Effectiveness" /><FieldValue Value="Timeliness" /></Field></Section><Section SecID="593" OrdBy="370" Name="Data Collection for the Measure"><Field FieldID="3506" OrdBy="380" ID="594" Name="Case Finding Period" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Unspecified&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="3054" OrdBy="390" ID="595" Name="Denominator Sampling Frame" Type="picklist-one"><FieldValue Value="Patients associated with provider" /></Field><Field FieldID="3057" OrdBy="400" ID="598" Name="Denominator (Index) Event or Characteristic" Type="picklist-choice"><FieldValue Value="Patient/Individual (Consumer) Characteristic" /><FieldValue Value="Therapeutic Intervention" /></Field><Field FieldID="3058" OrdBy="410" ID="599" Name="Denominator Time Window" Type="picklist-choice-3"><FieldValue Value="not defined yet" /></Field><Field FieldID="55" OrdBy="420" ID="596" Name="Denominator Inclusions/Exclusions" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;Inclusions&lt;/strong&gt;&lt;br /&gt;&#xD;&#xA;All surgical patients aged 18 years and older undergoing procedures for which venous thromboembolism (VTE) prophylaxis is indicated in all patients&lt;/p&gt;&#xD;&#xA;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Exclusions&lt;/strong&gt;&lt;br /&gt;&#xD;&#xA;Documentation of medical reason(s) for patient not receiving low-molecular weight heparin (LMWH), low-dose unfractionated heparin (LDUH), adjusted-dose warfarin, fondaparinux or mechanical prophylaxis within 24 hours prior to incision time or within 24 hours after surgery end time&lt;/p&gt;&#xD;&#xA;&lt;/div&gt;" /></Field><Field FieldID="3507" OrdBy="430" ID="597" Name="Exclusions/Exceptions" Type="picklist-choice-4"><FieldValue Value="not defined yet" /></Field><Field FieldID="59" OrdBy="440" ID="600" Name="Numerator Inclusions/Exclusions" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;Inclusions&lt;/strong&gt;&lt;br /&gt;&#xD;&#xA;Number of surgical patients from the denominator who had an order for low-molecular weight heparin (LMWH), low-dose unfractionated heparin (LDUH), adjusted-dose warfarin, fondaparinux or mechanical prophylaxis to be given within 24 hours prior to incision time or within 24 hours after surgery end time&lt;/p&gt;&#xD;&#xA;&#xD;&#xA;&lt;p class=&quot;Note&quot;&gt;&lt;strong&gt;Note&lt;/strong&gt;: There must be documentation of order (written order, verbal order, or standing order/protocol) for venous thromboembolism (VTE) prophylaxis &lt;strong&gt;OR&lt;/strong&gt; documentation that VTE prophylaxis was given.&lt;/p&gt;&#xD;&#xA;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Exclusions&lt;/strong&gt;&lt;br /&gt;&#xD;&#xA;None&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="3061" OrdBy="450" ID="601" Name="Numerator Search Strategy" Type="picklist-one"><FieldValue Value="Fixed time period or point in time" /></Field><Field FieldID="3062" OrdBy="460" ID="602" Name="Data Source" Type="picklist-many"><FieldValue Value="Administrative clinical data" /><FieldValue Value="Electronic health/medical record" /><FieldValue Value="Paper medical record" /></Field><Field FieldID="3065" OrdBy="470" ID="603" Name="Type of Health State" Type="picklist-one"><FieldValue Value="Does not apply to this measure" /></Field><Field FieldID="3066" OrdBy="480" ID="604" Name="Instruments Used and/or Associated with the Measure" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Unspecified&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="605" OrdBy="490" Name="Computation of the Measure"><Field FieldID="3508" OrdBy="500" ID="606" Name="Measure Specifies Disaggregation" Type="picklist-one"><FieldValue Value="Does not apply to this measure" /></Field><Field FieldID="3067" OrdBy="520" ID="608" Name="Scoring" Type="picklist-many"><FieldValue Value="Rate/Proportion" /></Field><Field FieldID="3068" OrdBy="530" ID="609" Name="Interpretation of Score" Type="picklist-one"><FieldValue Value="Desired value is a higher score" /></Field><Field FieldID="3090" OrdBy="540" ID="610" Name="Allowance for Patient or Population Factors" Type="picklist-choice-3"><FieldValue Value="not defined yet" /></Field><Field FieldID="3070" OrdBy="560" ID="612" Name="Standard of Comparison" Type="picklist-choice-3"><FieldValue Value="not defined yet" /></Field></Section><Section SecID="615" OrdBy="590" Name="Identifying Information"><Field FieldID="73" OrdBy="600" ID="616" Name="Original Title" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Measure #6: venous thromboembolism (VTE) prophylaxis (when indicated in ALL patients).&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="74" OrdBy="610" ID="617" Name="Measure Collection Name" Type="text"><FieldValue Value="The Physician Consortium for Performance Improvement&amp;#174; Measurement Sets" /></Field><Field FieldID="75" OrdBy="620" ID="618" Name="Measure Set Name" Type="text"><FieldValue Value="Perioperative Care Physician Performance Measurement Set" /></Field><Field FieldID="16" OrdBy="650" ID="621" Name="Submitter" Type="orglist"><FieldValue Value="American Medical Association on behalf of the American College of Surgeons, Physician Consortium for Performance Improvement®, and National Committee for Quality Assurance - Medical Specialty Society" /></Field><Field FieldID="17" OrdBy="660" ID="622" Name="Developer" Type="orglist-p"><FieldValue Value="American College of Surgeons - Medical Specialty Society" /><FieldValue Value="National Committee for Quality Assurance - Health Care Accreditation Organization" /><FieldValue Value="Physician Consortium for Performance Improvement® - Clinical Specialty Collaboration" /></Field><Field FieldID="79" OrdBy="670" ID="623" Name="Funding Source(s)" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Unspecified&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="80" OrdBy="680" ID="624" Name="Composition of the Group that Developed the Measure" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Ronald A. Gabel, MD (&lt;em&gt;Co-Chair&lt;/em&gt;); R. Scott Jones, MD, FACS (&lt;em&gt;Co-Chair&lt;/em&gt;); Priscilla Arnold, MD; Raj Behal, MD, MPH; Dale W. Bratzler, DO, MPH; Quentin Clemens, MD; Charles Drueck, MD, FACC; Fred Edwards, MD; Lee A. Fleisher, MD, FACC; Alex Hannenberg, MD; Daniel L. Herr, MS, MD, FCCM; David Hunt, MD, FACS; Kay Jewell, MD; Rahul K. Khare, MD, FACS; Shukri F. Khuri, MD, MBA; Rick Leary, MD, MBA; Kenneth Moore, MD; Mark Morasch, MD; Stephen Novack, DO; Frank Opelka, MD; Laura Orvidas, MD; Tom Read, MD; Sam J.W. Romeo, MD, MBA; Jerry Shuster, MD; Carl A. Sirio, MD; Sandra Tunajek, CRNA, ND; Patrick Voight, RN, BSN, MSA, CNOR; William Wooden, MD&lt;/p&gt;&#xD;&#xA;&#xD;&#xA;&lt;p&gt;Julie Lewis, American College of Surgeons; Karen Richards, American College of Surgeons&lt;/p&gt;&#xD;&#xA;&#xD;&#xA;&lt;p&gt;Mark S. Antman, DDS, MBA, American Medical Association; Karen S. Kmetik, PhD, American Medical Association; Beth Tapper, MA, American Medical Association; Samantha Tierney, MPH, American Medical Association&lt;/p&gt;&#xD;&#xA;&#xD;&#xA;&lt;p&gt;Joachim Roski, PhD, MPH, National Committee for Quality Assurance&lt;/p&gt;&#xD;&#xA;&#xD;&#xA;&lt;p&gt;Tom Croghan, MD; Latousha Leslie, RN, MS, Mathematica Policy Research, Centers for Medicare &amp; Medicaid Services; Sylvia Publ, MBA, RHIA, Mathematica Policy Research, Centers for Medicare &amp; Medicaid Services; Michael Rapp, MD, Mathematica Policy Research, Centers for Medicare &amp; Medicaid Services&lt;/p&gt;&#xD;&#xA;&#xD;&#xA;&lt;p&gt;Lisa Buczkowski, RN, MS, Joint Commission on Accreditation of Healthcare Organizations; Raquel Gabriel-Bennewitz, MS/MBA, BSN, RN, Joint Commission on Accreditation of Healthcare Organizations&lt;/p&gt;&#xD;&#xA;&#xD;&#xA;&lt;p&gt;Rebecca A. Kresowik, Facilitators; Timothy F. Kresowik, MD, Facilitator&lt;/p&gt;&#xD;&#xA;&lt;/div&gt;" /></Field><Field FieldID="81" OrdBy="690" ID="625" Name="Financial Disclosures/Other Potential Conflicts of Interest" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Conflicts, if any, are disclosed in accordance with the Physician Consortium for Performance Improvement&amp;#174; conflict of interest policy.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="82" OrdBy="700" ID="626" Name="Endorser" Type="orglist"><FieldValue Value="National Quality Forum - None" /></Field><Field FieldID="3091" OrdBy="705" ID="696" Name="NQF Number" Type="plain-text"><FieldValue Value="not defined yet" /></Field><Field FieldID="3510" OrdBy="710" ID="627" Name="Date of Endorsement" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;2014 Jan 30&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="3083" OrdBy="720" ID="628" Name="Measure Initiative(s)" Type="picklist-many"><FieldValue Value="Physician Quality Reporting System" /></Field><Field FieldID="19" OrdBy="730" ID="629" Name="Adaptation" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This measure was not adapted from another source.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="3086" OrdBy="740" ID="630" Name="Date of Most Current Version in NQMC" Type="date"><FieldValue Value="2006 Oct" /></Field><Field FieldID="3511" OrdBy="750" ID="631" Name="Measure Maintenance" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Unspecified&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="3512" OrdBy="760" ID="632" Name="Date of Next Anticipated Revision" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Unspecified&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="20" OrdBy="770" ID="633" Name="Measure Status" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This is the current release of the measure.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The Physician Consortium for Performance Improvement reaffirmed the currency of this measure in November 2011.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="14" OrdBy="780" ID="634" Name="Measure Availability" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;The individual measure, &quot;Measure #6: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients),&quot; is published in the &quot;Perioperative Care Physician Performance Measurement Set.&quot; This document and technical specifications are available in Portable Document Format (PDF) from the American Medical Association (AMA)-convened Physician Consortium for Performance Improvement&amp;reg; Web site: &lt;a href=&quot;http://www.physicianconsortium.org&quot; title=&quot;AMA Web site&quot;&gt;www.physicianconsortium.org&lt;/a&gt;.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;For further information, please contact AMA staff by e-mail at &lt;a href=&quot;mailto:cqi@ama-assn.org&quot;&gt;cqi@ama-assn.org&lt;/a&gt;.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="87" OrdBy="800" ID="636" Name="NQMC Status" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This NQMC summary was completed by ECRI Institute on September 13, 2007. The information was verified by the measure developer on October 26, 2007. This NQMC summary was retrofitted into the new template on June 8, 2011. The information was reaffirmed by the measure developer on November 30, 2011. &lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="88" OrdBy="810" ID="637" Name="Copyright Statement" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&amp;copy; Measures including specifications&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&amp;copy; 2005-6 American Medical Association and National Committee for Quality Assurance&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="641" OrdBy="850" Name="Production"><Field FieldID="1" OrdBy="1366" ID="562" Name="Source(s)" Type="citation"><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;American College of Surgeons, Physician Consortium for Performance Improvement®, National Committee for Quality Assurance. Perioperative care physician performance measurement set. Chicago (IL): American Medical Association, National Committee for Quality Assurance; 2006 Oct. 11 p.  [8 references]&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /></Field></Section><Section SecID="99999" OrdBy="99999" Name="Disclaimer"><Field FieldID="99999" OrdBy="99999" ID="99999" Name="NQMC Disclaimer" Type="text"><FieldValue Value="&lt;p&gt;The National Quality Measures Clearinghouse™ (NQMC) does not develop, produce, approve, or endorse the measures represented on this site.&lt;/p&gt; &lt;p&gt;All measures summarized by NQMC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public and private organizations, other government agencies, health care organizations or plans, individuals, and similar entities.&lt;/p&gt; &lt;p&gt;Measures represented on the NQMC Web site are submitted by measure developers, and are screened solely to determine that they meet the NQMC Inclusion Criteria which may be found at &lt;a href=&quot;../about/inclusion-criteria.aspx&quot;&gt;http://www.qualitymeasures.ahrq.gov/about/inclusion-criteria.aspx&lt;/a&gt;.&lt;/p&gt; &lt;p&gt;NQMC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or its reliability and/or validity of the quality measures and related materials represented on this site. Moreover, the views and opinions of developers or authors of measures represented on this site do not necessarily state or reflect those of NQMC, AHRQ, or its contractor, ECRI Institute, and inclusion or hosting of measures in NQMC may not be used for advertising or commercial endorsement purposes.&lt;/p&gt; &lt;p&gt;Readers with questions regarding measure content are directed to contact the measure developer.&lt;/p&gt;" /></Field></Section></Version>
